Conteltinib
CAS: 1384860-29-0
Ref. 3D-JFC86029
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Product Information
Conteltinib is an orally-administered, potent and selective inhibitor of fibroblast activation protein (FAP) that has been shown to inhibit the proliferation and migration of myofibroblasts in vitro. Conteltinib also inhibits the growth of various cancers in mice, including colorectal cancer, lung cancer, pancreatic cancer and prostate cancer. The mechanism by which conteltinib inhibits FAP is not known, but it may be due to multivalent binding or inhibition of FAP proteolytic activity. Conteltinib is being investigated as a potential treatment for fibrotic diseases such as idiopathic pulmonary fibrosis.
Chemical properties
Technical inquiry about: 3D-JFC86029 Conteltinib
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
